Selin ATAY-TDO- Swissmedic, the body that regulates treatment and health legislation in Switzerland, has approved a new type of coronavirus (Covid-19) vaccine developed by Pfizer and BioNTech.
Pfizer and BioNTech's vaccine had been allowed for "urgent use" in the UK, Canada and the US. However, Switzerland became the first country in the world to approve "standard procedures".
A written statement by Swissmedic said data from all age groups showed the vaccine met "high efficacy and safety requirements." The agency stressed that the vaccine was approved not for emergency use, but under "standard procedures", which is a first in the world. Swissmedic Director Raimund Bruhin said in a statement that they had acted rigorously in the approval process. Bruhin stated that the vaccine, developed by Pfizer and BioNTech, meets the "safety, efficacy and quality" criteria.
Switzerland has not ordered only Pfizer and BioNTech vaccine. The Swiss government also ordered a total of 15.8 million doses for the Covid-19 vaccines developed by Moderna and AstraZeneca.
Swiss Health Minister Alain Berset announced via Twitter that vaccinations would begin within days. The health secretary stressed that the vaccine would be available free to the public and said they "strongly" recommended it. According to planning by the Swedish government, widespread vaccination in the country is expected to begin with the first batch of 100 thousand doses from January 4. As a result of the vaccine campaign, which will last until the summer, 6 million people are expected to be vaccinated.